<!DOCTYPE html>
<html class="client-nojs" dir="ltr" lang="en">
<head>
<meta charset="utf-8"/>
<title>NGR-hTNF (antitumor recombinant protein) - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"1b58fe9a-1fc2-4e3a-ac1d-91727506381f","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"NGR-hTNF_(antitumor_recombinant_protein)","wgTitle":"NGR-hTNF (antitumor recombinant protein)","wgCurRevisionId":951192383,"wgRevisionId":951192383,"wgArticleId":42763448,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 errors: external links","CS1 errors: dates","Articles lacking reliable references from May 2014","All articles lacking reliable references","Wikipedia articles that are too technical from May 2014","All articles that are too technical",
"Articles with multiple maintenance issues","Official website not in Wikidata","Cancer treatments","Recombinant proteins"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"NGR-hTNF_(antitumor_recombinant_protein)","wgRelevantArticleId":42763448,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgCentralAuthMobileDomain":!1,"wgEditSubmitButtonLabelPublish":!0,"wgULSPosition":"interlanguage","wgWikibaseItemId":"Q17637123"};RLSTATE={
"ext.globalCssJs.user.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.styles.legacy":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.makeCollapsible","skins.vector.legacy.js","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.refToolbar","ext.gadget.switcher","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.compactlinks","ext.uls.interface","ext.cx.eventlogging.campaigns",
"ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector"></script>
<meta content="" name="ResourceLoaderDynamicStyles"/>
<link href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector" rel="stylesheet"/>
<meta content="MediaWiki 1.36.0-wmf.10" name="generator"/>
<meta content="origin" name="referrer"/>
<meta content="origin-when-crossorigin" name="referrer"/>
<meta content="origin-when-cross-origin" name="referrer"/>
<link href="//en.m.wikipedia.org/wiki/NGR-hTNF_(antitumor_recombinant_protein)" media="only screen and (max-width: 720px)" rel="alternate"/>
<link href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit" rel="alternate" title="Edit this page" type="application/x-wiki"/>
<link href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit" rel="edit" title="Edit this page"/>
<link href="/static/apple-touch/wikipedia.png" rel="apple-touch-icon"/>
<link href="/static/favicon/wikipedia.ico" rel="shortcut icon"/>
<link href="/w/opensearch_desc.php" rel="search" title="Wikipedia (en)" type="application/opensearchdescription+xml"/>
<link href="//en.wikipedia.org/w/api.php?action=rsd" rel="EditURI" type="application/rsd+xml"/>
<link href="//creativecommons.org/licenses/by-sa/3.0/" rel="license"/>
<link href="https://en.wikipedia.org/wiki/NGR-hTNF_(antitumor_recombinant_protein)" rel="canonical"/>
<link href="//login.wikimedia.org" rel="dns-prefetch"/>
<link href="//meta.wikimedia.org" rel="dns-prefetch"/>
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-NGR-hTNF_antitumor_recombinant_protein rootpage-NGR-hTNF_antitumor_recombinant_protein skin-vector action-view skin-vector-legacy"><div class="noprint" id="mw-page-base"></div>
<div class="noprint" id="mw-head-base"></div>
<div class="mw-body" id="content" role="main">
<a id="top"></a>
<div class="mw-body-content" id="siteNotice"><!-- CentralNotice --></div>
<div class="mw-indicators mw-body-content">
</div>
<h1 class="firstHeading" id="firstHeading" lang="en">NGR-hTNF (antitumor recombinant protein)</h1>
<div class="mw-body-content" id="bodyContent">
<div class="noprint" id="siteSub">From Wikipedia, the free encyclopedia</div>
<div id="contentSub"></div>
<div id="contentSub2"></div>
<div id="jump-to-nav"></div>
<a class="mw-jump-link" href="#mw-head">Jump to navigation</a>
<a class="mw-jump-link" href="#searchInput">Jump to search</a>
<div class="mw-content-ltr" dir="ltr" id="mw-content-text" lang="en"><div class="mw-parser-output"><table class="box-Multiple_issues plainlinks metadata ambox ambox-content ambox-multiple_issues compact-ambox" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" data-file-height="40" data-file-width="40" decoding="async" height="40" src="//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x" width="40"/></div></td><td class="mbox-text"><div class="mbox-text-span"><div class="mw-collapsible" style="width:95%; margin: 0.2em 0;"><b>This article has multiple issues.</b> Please help <b><a class="external text" href="https://en.wikipedia.org/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit">improve it</a></b> or discuss these issues on the <b><a href="/wiki/Talk:NGR-hTNF_(antitumor_recombinant_protein)" title="Talk:NGR-hTNF (antitumor recombinant protein)">talk page</a></b>. <small><i>(<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove these template messages</a>)</i></small>
<div class="mw-collapsible-content" style="margin-top: 0.3em;">
<table class="box-Third-party plainlinks metadata ambox ambox-content" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><a class="image" href="/wiki/File:Question_book-new.svg"><img alt="Question book-new.svg" data-file-height="399" data-file-width="512" decoding="async" height="39" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" width="50"/></a></div></td><td class="mbox-text"><div class="mbox-text-span">This article <b>may rely excessively on sources <a href="/wiki/Wikipedia:Verifiability#Self-published_sources" title="Wikipedia:Verifiability">too closely associated with the subject</a></b>, potentially preventing the article from being <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verifiable</a> and <a href="/wiki/Wikipedia:Neutral_point_of_view" title="Wikipedia:Neutral point of view">neutral</a>.<span class="hide-when-compact"> Please help <a class="external text" href="https://en.wikipedia.org/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit">improve it</a> by replacing them with more appropriate <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">citations</a> to <a class="mw-redirect" href="/wiki/Wikipedia:Identifying_and_using_independent_sources" title="Wikipedia:Identifying and using independent sources">reliable, independent, third-party sources</a>.</span> <small class="date-container"><i>(<span class="date">May 2014</span>)</i></small><small class="hide-when-compact"><i> (<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>
<table class="box-Technical plainlinks metadata ambox ambox-style ambox-technical" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" data-file-height="48" data-file-width="48" decoding="async" height="40" src="//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/40px-Edit-clear.svg.png" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/60px-Edit-clear.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/80px-Edit-clear.svg.png 2x" width="40"/></div></td><td class="mbox-text"><div class="mbox-text-span">This article <b>may be too technical for most readers to understand</b>. Please <a class="external text" href="https://en.wikipedia.org/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit">help improve it</a> to <a href="/wiki/Wikipedia:Make_technical_articles_understandable" title="Wikipedia:Make technical articles understandable">make it understandable to non-experts</a>, without removing the technical details.  <small class="date-container"><i>(<span class="date">May 2014</span>)</i></small><small class="hide-when-compact"><i> (<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>
</div>
</div><small class="hide-when-compact"><i> (<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>
<p><b>NGR-hTNF</b> is an <a href="/wiki/Experimental_drug" title="Experimental drug">experimental</a> antitumor drug designed to act on <a class="mw-redirect" href="/wiki/Tumor" title="Tumor">tumor</a> blood vessels.<sup class="reference" id="cite_ref-NGR_hTNF_among_the_Top_10_1-0"><a href="#cite_note-NGR_hTNF_among_the_Top_10-1">[1]</a></sup><sup class="reference" id="cite_ref-2"><a href="#cite_note-2">[2]</a></sup><sup class="reference" id="cite_ref-MolMed_a_New_Patent_on_Its_Anticancer_Drug_NGR-hTNF_3-0"><a href="#cite_note-MolMed_a_New_Patent_on_Its_Anticancer_Drug_NGR-hTNF-3">[3]</a></sup> It is currently undergoing <a class="mw-redirect" href="/wiki/Phase_III_clinical_trial" title="Phase III clinical trial">Phase III clinical trials</a> <sup class="reference" id="cite_ref-MolMed_PhaseIII_Trial_on_NGRhTNF_4-0"><a href="#cite_note-MolMed_PhaseIII_Trial_on_NGRhTNF-4">[4]</a></sup> for treatment of malignant pleural  <a href="/wiki/Mesothelioma" title="Mesothelioma">mesothelioma</a> caused by exposure to <a href="/wiki/Asbestos" title="Asbestos">asbestos</a>.<sup class="reference" id="cite_ref-Multidisciplinary_treatment_5-0"><a href="#cite_note-Multidisciplinary_treatment-5">[5]</a></sup><sup class="reference" id="cite_ref-MolMed_starts_Phase_III_of_NGRhTNF_6-0"><a href="#cite_note-MolMed_starts_Phase_III_of_NGRhTNF-6">[6]</a></sup><sup class="reference" id="cite_ref-7"><a href="#cite_note-7">[7]</a></sup>  NGR-hTNF is also being investigated, alone or in combination with <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>,<sup class="reference" id="cite_ref-8"><a href="#cite_note-8">[8]</a></sup> on four different solid tumors<sup class="reference" id="cite_ref-9"><a href="#cite_note-9">[9]</a></sup><sup class="reference" id="cite_ref-10"><a href="#cite_note-10">[10]</a></sup>  in four other randomized Phase II trials.<sup class="reference" id="cite_ref-MolMed_new_data_ngr_htnf_11-0"><a href="#cite_note-MolMed_new_data_ngr_htnf-11">[11]</a></sup>
</p><p>NGR-hTNF is a <a class="mw-redirect" href="/wiki/Recombinant_protein" title="Recombinant protein">recombinant protein</a> derived from the fusion between peptide CNGRCG <sup class="reference" id="cite_ref-Safety_and_anticancer_activity_of_low_dose_regimen_of_NGR-hTNF_12-0"><a href="#cite_note-Safety_and_anticancer_activity_of_low_dose_regimen_of_NGR-hTNF-12">[12]</a></sup> and human <a class="mw-redirect" href="/wiki/Tumor_necrosis_factor_alpha" title="Tumor necrosis factor alpha">tumor necrosis factor alpha</a>
<sup class="reference" id="cite_ref-13"><a href="#cite_note-13">[13]</a></sup> (TNFα).<sup class="reference" id="cite_ref-Improving_chemotherapeutic_drug_penetration_in_tumors_by_vascular_targeting_and_barrier_alteration_14-0"><a href="#cite_note-Improving_chemotherapeutic_drug_penetration_in_tumors_by_vascular_targeting_and_barrier_alteration-14">[14]</a></sup><sup class="reference" id="cite_ref-15"><a href="#cite_note-15">[15]</a></sup>
Once it has reached the tumor, NGR-hTNF performs its <a class="mw-redirect" href="/wiki/Antitumor" title="Antitumor">antitumor</a> action.<sup class="reference" id="cite_ref-16"><a href="#cite_note-16">[16]</a></sup> 
The Phase III (NGR015) <sup class="reference" id="cite_ref-MolMed_Completes_Enrolment_in_Pivotal_Phase_III_17-0"><a href="#cite_note-MolMed_Completes_Enrolment_in_Pivotal_Phase_III-17">[17]</a></sup> clinical trial is in progress in 35 clinical centers in Europe (Italy, UK, Ireland, Poland and Belgium), USA, Canada and Egypt. NGR-hTNF is the only drug being tested in Phase III trials <sup class="reference" id="cite_ref-MolMed_starts_Phase_III_trial_of_NGR-hTNF_in_mesothelioma_18-0"><a href="#cite_note-MolMed_starts_Phase_III_trial_of_NGR-hTNF_in_mesothelioma-18">[18]</a></sup> for the treatment of relapsed Mesothelioma, and has been granted <a href="/wiki/Orphan_drug" title="Orphan drug">Orphan Drug</a> designation both in Europe and USA.
<sup class="reference" id="cite_ref-US_FDA_Grants_Orphan_Status_to_Mesothelioma_Drug_19-0"><a href="#cite_note-US_FDA_Grants_Orphan_Status_to_Mesothelioma_Drug-19">[19]</a></sup><sup class="reference" id="cite_ref-MolMed_Expands_Phase_III_Trial_of_NGR-hTNF_for_the_Treatment_of_Mesothelioma_in_the_United_States_20-0"><a href="#cite_note-MolMed_Expands_Phase_III_Trial_of_NGR-hTNF_for_the_Treatment_of_Mesothelioma_in_the_United_States-20">[20]</a></sup>
</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit&amp;section=1" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-NGR_hTNF_among_the_Top_10-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-NGR_hTNF_among_the_Top_10_1-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="http://www.biotechnology-europe.com/news/news%20by%20company/Molmed/15.10.2010%20NGR-hTNF%20among%20the%20Top%2010%20most%20interesting%20oncology%20projects%20to%20watch.html" rel="nofollow">"NGR hTNF among the Top 10"</a>. <a class="external free" href="http://www.biotechnology-europe.com" rel="nofollow">http://www.biotechnology-europe.com</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NGR+hTNF+among+the+Top+10&amp;rft.pub=http%3A%2F%2Fwww.biotechnology-europe.com&amp;rft_id=http%3A%2F%2Fwww.biotechnology-europe.com%2Fnews%2Fnews%2520by%2520company%2FMolmed%2F15.10.2010%2520NGR-hTNF%2520among%2520the%2520Top%252010%2520most%2520interesting%2520oncology%2520projects%2520to%2520watch.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg");background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg");background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg");background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png");background-image:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg");background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><cite class="citation journal cs1" id="CITEREFLorussoScambiaAmadiodi_Legge2012">Lorusso D, Scambia G, Amadio G, di Legge A, Pietragalla A, De Vincenzo R, Masciullo V, Di Stefano M, Mangili G, Citterio G, Mantori M, Lambiase A, Bordignon C (Jun 2012). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3389423" rel="nofollow">"Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients"</a>. <i>British Journal of Cancer</i>. <b>107</b> (1): 37–42. <a class="mw-redirect" href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a class="external text" href="https://doi.org/10.1038%2Fbjc.2012.233" rel="nofollow">10.1038/bjc.2012.233</a>. <a class="mw-redirect" href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3389423" rel="nofollow">3389423</a></span>. <a class="mw-redirect" href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a> <a class="external text" href="//pubmed.ncbi.nlm.nih.gov/22644293" rel="nofollow">22644293</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Cancer&amp;rft.atitle=Phase+II+study+of+NGR-hTNF+in+combination+with+doxorubicin+in+relapsed+ovarian+cancer+patients&amp;rft.volume=107&amp;rft.issue=1&amp;rft.pages=37-42&amp;rft.date=2012-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3389423&amp;rft_id=info%3Apmid%2F22644293&amp;rft_id=info%3Adoi%2F10.1038%2Fbjc.2012.233&amp;rft.aulast=Lorusso&amp;rft.aufirst=D&amp;rft.au=Scambia%2C+G&amp;rft.au=Amadio%2C+G&amp;rft.au=di+Legge%2C+A&amp;rft.au=Pietragalla%2C+A&amp;rft.au=De+Vincenzo%2C+R&amp;rft.au=Masciullo%2C+V&amp;rft.au=Di+Stefano%2C+M&amp;rft.au=Mangili%2C+G&amp;rft.au=Citterio%2C+G&amp;rft.au=Mantori%2C+M&amp;rft.au=Lambiase%2C+A&amp;rft.au=Bordignon%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3389423&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-MolMed_a_New_Patent_on_Its_Anticancer_Drug_NGR-hTNF-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-MolMed_a_New_Patent_on_Its_Anticancer_Drug_NGR-hTNF_3-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="https://finance.yahoo.com/news/european-patent-office-grants-molmed-053300980.html" rel="nofollow">"MolMed a New Patent on Its Anticancer Drug NGR-hTNF"</a>. <a class="external free" href="http://finance.yahoo.com" rel="nofollow">http://finance.yahoo.com</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MolMed+a+New+Patent+on+Its+Anticancer+Drug+NGR-hTNF&amp;rft.pub=http%3A%2F%2Ffinance.yahoo.com&amp;rft_id=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Feuropean-patent-office-grants-molmed-053300980.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-MolMed_PhaseIII_Trial_on_NGRhTNF-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-MolMed_PhaseIII_Trial_on_NGRhTNF_4-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="http://www.biotechnology-europe.com/news/news%20by%20company/Molmed/2012/13.12.2012%20MolMed%20completes%20enrolment%20in%20pivotal%20Phase%20III%20trial%20of%20NGR-hTNF%20in%20relapsed%20mesothelioma%20patients.html" rel="nofollow">"MolMed PhaseIII Trial on NGRhTNF"</a>. <a class="external free" href="http://www.biotechnology-europe.com" rel="nofollow">http://www.biotechnology-europe.com</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MolMed+PhaseIII+Trial+on+NGRhTNF&amp;rft.pub=http%3A%2F%2Fwww.biotechnology-europe.com&amp;rft_id=http%3A%2F%2Fwww.biotechnology-europe.com%2Fnews%2Fnews%2520by%2520company%2FMolmed%2F2012%2F13.12.2012%2520MolMed%2520completes%2520enrolment%2520in%2520pivotal%2520Phase%2520III%2520trial%2520of%2520NGR-hTNF%2520in%2520relapsed%2520mesothelioma%2520patients.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Multidisciplinary_treatment-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-Multidisciplinary_treatment_5-0">^</a></b></span> <span class="reference-text"><cite class="citation journal cs1" id="CITEREFCeresoliGridelliSantoro2007">Ceresoli GL, Gridelli C, Santoro A (July 2007). "Multidisciplinary treatment". <i>Oncologist</i>. <b>12</b> (7): 850–63. <a class="mw-redirect" href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a class="external text" href="https://doi.org/10.1634%2Ftheoncologist.12-7-850" rel="nofollow">10.1634/theoncologist.12-7-850</a>. <a class="mw-redirect" href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a> <a class="external text" href="//pubmed.ncbi.nlm.nih.gov/17673616" rel="nofollow">17673616</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncologist&amp;rft.atitle=Multidisciplinary+treatment&amp;rft.volume=12&amp;rft.issue=7&amp;rft.pages=850-63&amp;rft.date=2007-07&amp;rft_id=info%3Adoi%2F10.1634%2Ftheoncologist.12-7-850&amp;rft_id=info%3Apmid%2F17673616&amp;rft.aulast=Ceresoli&amp;rft.aufirst=GL&amp;rft.au=Gridelli%2C+C&amp;rft.au=Santoro%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-MolMed_starts_Phase_III_of_NGRhTNF-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-MolMed_starts_Phase_III_of_NGRhTNF_6-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="http://www.mesotheliomacenter.org/mesothelioma-news/2010/04/20/molmed-starts-phase-iii-trial-of-ngr-htnf-in-mesothelioma/" rel="nofollow">"MolMed starts Phase III of NGRhTNF"</a>. <a class="external free" href="http://www.mesotheliomacenter.org" rel="nofollow">http://www.mesotheliomacenter.org</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MolMed+starts+Phase+III+of+NGRhTNF&amp;rft.pub=http%3A%2F%2Fwww.mesotheliomacenter.org&amp;rft_id=http%3A%2F%2Fwww.mesotheliomacenter.org%2Fmesothelioma-news%2F2010%2F04%2F20%2Fmolmed-starts-phase-iii-trial-of-ngr-htnf-in-mesothelioma%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation cs2" id="CITEREFCeresoliGridelliSantoro2007">Ceresoli GL, Gridelli C, Santoro A (2007), <i>Multidisciplinary treatment of malignant pleural mesothelioma. Oncologist.</i>, pp. 12:850–863</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Multidisciplinary+treatment+of+malignant+pleural+mesothelioma.+Oncologist.&amp;rft.pages=12%3A850-863&amp;rft.date=2007&amp;rft.aulast=Ceresoli&amp;rft.aufirst=GL&amp;rft.au=Gridelli%2C+C&amp;rft.au=Santoro%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation cs2" id="CITEREFCurnisSacchiCortiJ_Clin_Invest">Curnis F, Sacchi A, Corti A, J Clin Invest (2002b web), "Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration", <i>Journal of Clinical Investigation</i>, <b>110</b> (4): 110:475–482, <a class="mw-redirect" href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a class="external text" href="https://doi.org/10.1172%2Fjci0215223" rel="nofollow">10.1172/jci0215223</a>, <a class="mw-redirect" href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC150417" rel="nofollow">150417</a></span>, <a class="mw-redirect" href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a> <a class="external text" href="//pubmed.ncbi.nlm.nih.gov/12189241" rel="nofollow">12189241</a></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Investigation&amp;rft.atitle=Improving+chemotherapeutic+drug+penetration+in+tumors+by+vascular+targeting+and+barrier+alteration&amp;rft.chron=2002b+web&amp;rft.volume=110&amp;rft.issue=4&amp;rft.pages=110%3A475-482&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC150417&amp;rft_id=info%3Apmid%2F12189241&amp;rft_id=info%3Adoi%2F10.1172%2Fjci0215223&amp;rft.aulast=Curnis&amp;rft.aufirst=F&amp;rft.au=Sacchi%2C+A&amp;rft.au=Corti%2C+A&amp;rft.au=J+Clin+Invest&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">Check date values in: <code class="cs1-code">|date=</code> (<a href="/wiki/Help:CS1_errors#bad_date" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><cite class="citation cs2" id="CITEREFLorussoScambiaAmadioDi_Legge2012">Lorusso D, Scambia G, Amadio G, Di Legge A, Pietragalla A, De Vincenzo R, masciullo V, Di Stefano M, Mangilli G, Citterio G, Mantori M, Lambiase A, Bordignon C (2012-06-26), <i>Phase II study of NGR-hTNF in combination with doxorubicina in relapsed ovarian cancer patients. Br J Cancer</i>, pp. 107(1):37–42</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Phase+II+study+of+NGR-hTNF+in+combination+with+doxorubicina+in+relapsed+ovarian+cancer+patients.+Br+J+Cancer&amp;rft.pages=107%281%29%3A37-42&amp;rft.date=2012-06-26&amp;rft.aulast=Lorusso&amp;rft.aufirst=D&amp;rft.au=Scambia%2C+G&amp;rft.au=Amadio%2C+G&amp;rft.au=Di+Legge%2C+A&amp;rft.au=Pietragalla%2C+A&amp;rft.au=De+Vincenzo%2C+R&amp;rft.au=masciullo%2C+V&amp;rft.au=Di+Stefano%2C+M&amp;rft.au=Mangilli%2C+G&amp;rft.au=Citterio%2C+G&amp;rft.au=Mantori%2C+M&amp;rft.au=Lambiase%2C+A&amp;rft.au=Bordignon%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><cite class="citation cs2" id="CITEREFGregorcDe_BraudDe_Passcalamogna2011">Gregorc V, De Braud FG, De Pas TM, scalamogna R, Citterio G, Milani A, Boselli S, Catania C, Donadoni G, Rossoni G, Ghio D, Spitaleri G, Ammannati C, Colombi S, Caligaris-Capio F, Lambiase A, Bordignon C (Apr 2011), "Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractary solid tumors. Clin Cancer Res", <i>Clin. Cancer Res.</i>, <b>17</b> (7): 107(1):37–42 1, 17 (7): 1964–72, <a class="mw-redirect" href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a class="external text" href="https://doi.org/10.1158%2F1078-0432.CCR-10-1376" rel="nofollow">10.1158/1078-0432.CCR-10-1376</a></span>, <a class="mw-redirect" href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a> <a class="external text" href="//pubmed.ncbi.nlm.nih.gov/21307147" rel="nofollow">21307147</a></cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Cancer+Res.&amp;rft.atitle=Phase+I+study+of+NGR-hTNF%2C+a+selective+vascular+targeting+agent%2C+in+combination+with+cisplatin+in+refractary+solid+tumors.+Clin+Cancer+Res&amp;rft.volume=17&amp;rft.issue=7&amp;rft.pages=107%281%29%3A37-42+1%2C+17+%287%29%3A+1964-72&amp;rft.date=2011-04&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-10-1376&amp;rft_id=info%3Apmid%2F21307147&amp;rft.aulast=Gregorc&amp;rft.aufirst=V&amp;rft.au=De+Braud%2C+FG&amp;rft.au=De+Pas%2C+TM&amp;rft.au=scalamogna%2C+R&amp;rft.au=Citterio%2C+G&amp;rft.au=Milani%2C+A&amp;rft.au=Boselli%2C+S&amp;rft.au=Catania%2C+C&amp;rft.au=Donadoni%2C+G&amp;rft.au=Rossoni%2C+G&amp;rft.au=Ghio%2C+D&amp;rft.au=Spitaleri%2C+G&amp;rft.au=Ammannati%2C+C&amp;rft.au=Colombi%2C+S&amp;rft.au=Caligaris-Capio%2C+F&amp;rft.au=Lambiase%2C+A&amp;rft.au=Bordignon%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-MolMed_new_data_ngr_htnf-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-MolMed_new_data_ngr_htnf_11-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="https://www.drugs.com/clinical_trials/molmed-presents-new-data-four-clinical-trials-ngr-htnf-european-multidisciplinary-cancer-congress-12421.html" rel="nofollow">"MolMed new data ngr htnf"</a>. <a class="external free" href="https://www.drugs.com" rel="nofollow">https://www.drugs.com</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MolMed+new+data+ngr+htnf&amp;rft.pub=https%3A%2F%2Fwww.drugs.com&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fclinical_trials%2Fmolmed-presents-new-data-four-clinical-trials-ngr-htnf-european-multidisciplinary-cancer-congress-12421.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Safety_and_anticancer_activity_of_low_dose_regimen_of_NGR-hTNF-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-Safety_and_anticancer_activity_of_low_dose_regimen_of_NGR-hTNF_12-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="http://www.molmed.com/sites/default/files/uploads/publications/1057/asco_2007_p3540_ngr.pdf" rel="nofollow">"Safety and anticancer activity of low dose regimen of NGR-hTNF"</a> <span class="cs1-format">(PDF)</span>. www.molmed.com.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Safety+and+anticancer+activity+of+low+dose+regimen+of+NGR-hTNF&amp;rft.pub=www.molmed.com&amp;rft_id=http%3A%2F%2Fwww.molmed.com%2Fsites%2Fdefault%2Ffiles%2Fuploads%2Fpublications%2F1057%2Fasco_2007_p3540_ngr.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><cite class="citation cs2" id="CITEREFCurnisSacchiBorgnaMagni2000">Curnis F, Sacchi A, Borgna L, Magni F, Gasparri A, Corti A (2000), <i>Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol</i>, pp. 18:1185–1190</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Enhancement+of+tumor+necrosis+factor+alpha+antitumor+immunotherapeutic+properties+by+targeted+delivery+to+aminopeptidase+N+%28CD13%29.+Nat+Biotechnol&amp;rft.pages=18%3A1185-1190&amp;rft.date=2000&amp;rft.aulast=Curnis&amp;rft.aufirst=F&amp;rft.au=Sacchi%2C+A&amp;rft.au=Borgna%2C+L&amp;rft.au=Magni%2C+F&amp;rft.au=Gasparri%2C+A&amp;rft.au=Corti%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-Improving_chemotherapeutic_drug_penetration_in_tumors_by_vascular_targeting_and_barrier_alteration-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Improving_chemotherapeutic_drug_penetration_in_tumors_by_vascular_targeting_and_barrier_alteration_14-0">^</a></b></span> <span class="reference-text"><cite class="citation journal cs1" id="CITEREFCurnisSacchiCorti2002">Curnis, Flavio; Sacchi, Angelina; Corti, Angelo (2002). <a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC150417" rel="nofollow">"Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration"</a>. <i>Journal of Clinical Investigation</i>. <b>110</b> (4): 475–482. <a class="mw-redirect" href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a class="external text" href="https://doi.org/10.1172%2Fjci0215223" rel="nofollow">10.1172/jci0215223</a>. <a class="mw-redirect" href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC150417" rel="nofollow">150417</a></span>. <a class="mw-redirect" href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a> <a class="external text" href="//pubmed.ncbi.nlm.nih.gov/12189241" rel="nofollow">12189241</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Investigation&amp;rft.atitle=Improving+chemotherapeutic+drug+penetration+in+tumors+by+vascular+targeting+and+barrier+alteration&amp;rft.volume=110&amp;rft.issue=4&amp;rft.pages=475-482&amp;rft.date=2002&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC150417&amp;rft_id=info%3Apmid%2F12189241&amp;rft_id=info%3Adoi%2F10.1172%2Fjci0215223&amp;rft.aulast=Curnis&amp;rft.aufirst=Flavio&amp;rft.au=Sacchi%2C+Angelina&amp;rft.au=Corti%2C+Angelo&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC150417&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><cite class="citation cs2"><i>Fiers. Biologic therapy with TNF: preclinical studies. In: Company JL, ed. Biologic therapy of cancer: principles and practice</i>, Philadelphia: (ed V De Vita, S Hellman and S Rosenberg (edts))., pp. 1995:295</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Fiers.+Biologic+therapy+with+TNF%3A+preclinical+studies.+In%3A+Company+JL%2C+ed.+Biologic+therapy+of+cancer%3A+principles+and+practice&amp;rft.place=Philadelphia&amp;rft.pages=1995%3A295&amp;rft.pub=%28ed+V+De+Vita%2C+S+Hellman+and+S+Rosenberg+%28edts%29%29.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><cite class="citation journal cs1" id="CITEREFGregorcDe_BraudDe_PasScalamogna2011">Gregorc V, De Braud FG, De Pas TM, Scalamogna R, Citterio G, Milani A, Boselli S, Catania C, Donadoni G, Rossoni G, Ghio D, Spitaleri G, Ammannati C, Colombi S, Caligaris-Cappio F, Lambiase A, Bordignon C (Apr 2011). <a class="external text" href="https://doi.org/10.1158/1078-0432.CCR-10-1376" rel="nofollow">"Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors"</a>. <i>Clinical Cancer Research</i>. <b>17</b> (7): 1964–72. <a class="mw-redirect" href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a class="external text" href="https://doi.org/10.1158%2F1078-0432.CCR-10-1376" rel="nofollow">10.1158/1078-0432.CCR-10-1376</a></span>. <a class="mw-redirect" href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a> <a class="external text" href="//pubmed.ncbi.nlm.nih.gov/21307147" rel="nofollow">21307147</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=Phase+I+study+of+NGR-hTNF%2C+a+selective+vascular+targeting+agent%2C+in+combination+with+cisplatin+in+refractory+solid+tumors&amp;rft.volume=17&amp;rft.issue=7&amp;rft.pages=1964-72&amp;rft.date=2011-04&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-10-1376&amp;rft_id=info%3Apmid%2F21307147&amp;rft.aulast=Gregorc&amp;rft.aufirst=V&amp;rft.au=De+Braud%2C+FG&amp;rft.au=De+Pas%2C+TM&amp;rft.au=Scalamogna%2C+R&amp;rft.au=Citterio%2C+G&amp;rft.au=Milani%2C+A&amp;rft.au=Boselli%2C+S&amp;rft.au=Catania%2C+C&amp;rft.au=Donadoni%2C+G&amp;rft.au=Rossoni%2C+G&amp;rft.au=Ghio%2C+D&amp;rft.au=Spitaleri%2C+G&amp;rft.au=Ammannati%2C+C&amp;rft.au=Colombi%2C+S&amp;rft.au=Caligaris-Cappio%2C+F&amp;rft.au=Lambiase%2C+A&amp;rft.au=Bordignon%2C+C&amp;rft_id=%2F%2Fdoi.org%2F10.1158%2F1078-0432.CCR-10-1376&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-MolMed_Completes_Enrolment_in_Pivotal_Phase_III-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-MolMed_Completes_Enrolment_in_Pivotal_Phase_III_17-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="http://www.evaluategroup.com/Universal/View.aspx?type=Story&amp;id=369828" rel="nofollow">"MolMed Completes Enrolment in Pivotal Phase III"</a>. <a class="external free" href="http://www.evaluategroup.com/" rel="nofollow">http://www.evaluategroup.com/</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MolMed+Completes+Enrolment+in+Pivotal+Phase+III&amp;rft.pub=http%3A%2F%2Fwww.evaluategroup.com%2F&amp;rft_id=http%3A%2F%2Fwww.evaluategroup.com%2FUniversal%2FView.aspx%3Ftype%3DStory%26id%3D369828&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-MolMed_starts_Phase_III_trial_of_NGR-hTNF_in_mesothelioma-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-MolMed_starts_Phase_III_trial_of_NGR-hTNF_in_mesothelioma_18-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="http://www.molmed.com/sites/default/files/uploads/press-releases/1291-molmed_starts_phase_iii_trial_of_ngr-htnf_in_mesothelioma/1291_1337707610.pdf" rel="nofollow">"MolMed starts Phase III trial of NGR-hTNF in mesothelioma"</a> <span class="cs1-format">(PDF)</span>. <a class="external free" href="http://www.molmed.com/" rel="nofollow">http://www.molmed.com/</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MolMed+starts+Phase+III+trial+of+NGR-hTNF+in+mesothelioma&amp;rft.pub=http%3A%2F%2Fwww.molmed.com%2F&amp;rft_id=http%3A%2F%2Fwww.molmed.com%2Fsites%2Fdefault%2Ffiles%2Fuploads%2Fpress-releases%2F1291-molmed_starts_phase_iii_trial_of_ngr-htnf_in_mesothelioma%2F1291_1337707610.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-US_FDA_Grants_Orphan_Status_to_Mesothelioma_Drug-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-US_FDA_Grants_Orphan_Status_to_Mesothelioma_Drug_19-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="http://www.asbestos.net/newsroom/news/2008/09/23/us-fda-grants-orphan-status-to-mesothelioma-drug" rel="nofollow">"US FDA Grants Orphan Status to Mesothelioma Drug"</a>. <a class="external free" href="http://www.asbestos.net/" rel="nofollow">http://www.asbestos.net/</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=US+FDA+Grants+Orphan+Status+to+Mesothelioma+Drug&amp;rft.pub=http%3A%2F%2Fwww.asbestos.net%2F&amp;rft_id=http%3A%2F%2Fwww.asbestos.net%2Fnewsroom%2Fnews%2F2008%2F09%2F23%2Fus-fda-grants-orphan-status-to-mesothelioma-drug&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
<li id="cite_note-MolMed_Expands_Phase_III_Trial_of_NGR-hTNF_for_the_Treatment_of_Mesothelioma_in_the_United_States-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-MolMed_Expands_Phase_III_Trial_of_NGR-hTNF_for_the_Treatment_of_Mesothelioma_in_the_United_States_20-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a class="external text" href="https://finance.yahoo.com/news/MolMed-Expands-Phase-III-iw-3171791129.html" rel="nofollow">"MolMed Expands Phase III Trial of NGR-hTNF for the Treatment of Mesothelioma in the United States"</a>. <a class="external free" href="https://finance.yahoo.com/" rel="nofollow">https://finance.yahoo.com/</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=MolMed+Expands+Phase+III+Trial+of+NGR-hTNF+for+the+Treatment+of+Mesothelioma+in+the+United+States&amp;rft.pub=https%3A%2F%2Ffinance.yahoo.com%2F&amp;rft_id=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2FMolMed-Expands-Phase-III-iw-3171791129.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANGR-hTNF+%28antitumor+recombinant+protein%29"></span> <span class="cs1-visible-error error citation-comment">External link in <code class="cs1-code">|publisher=</code> (<a href="/wiki/Help:CS1_errors#param_has_ext_link" title="Help:CS1 errors">help</a>)</span><link href="mw-data:TemplateStyles:r951705291" rel="mw-deduplicated-inline-style"/></span>
</li>
</ol></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit&amp;section=2" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><span class="official-website"><span class="url"><a class="external text" href="http://www.molmed.com/node/1868" rel="nofollow">Official website</a></span></span></li></ul>
<!-- 
NewPP limit report
Parsed by mw2333
Cached time: 20201005081409
Cache expiry: 2592000
Dynamic content: false
Complications: [vary‐revision‐sha1]
CPU time usage: 0.316 seconds
Real time usage: 0.405 seconds
Preprocessor visited node count: 1079/1000000
Post‐expand include size: 72626/2097152 bytes
Template argument size: 7200/2097152 bytes
Highest expansion depth: 19/40
Expensive parser function count: 2/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 86949/5000000 bytes
Lua time usage: 0.188/10.000 seconds
Lua memory usage: 4.88 MB/50 MB
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  372.357      1 -total
 54.86%  204.287      1 Template:Reflist
 30.69%  114.283      1 Template:Multiple_issues
 28.23%  105.111     10 Template:Cite_web
 28.09%  104.602      3 Template:Ambox
 11.03%   41.073      6 Template:Citation
 10.03%   37.329      1 Template:Official_website
  7.71%   28.713      1 Template:Technical
  7.64%   28.445      4 Template:Cite_journal
  6.00%   22.353      1 Template:Third-party
-->
<!-- Saved in parser cache with key enwiki:pcache:idhash:42763448-0!canonical and timestamp 20201005081409 and revision id 951192383
 -->
</div><noscript><img alt="" height="1" src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" style="border: none; position: absolute;" title="" width="1"/></noscript>
<div class="printfooter">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;oldid=951192383">https://en.wikipedia.org/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;oldid=951192383</a>"</div></div>
<div class="catlinks" data-mw="interface" id="catlinks"><div class="mw-normal-catlinks" id="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Cancer_treatments" title="Category:Cancer treatments">Cancer treatments</a></li><li><a href="/wiki/Category:Recombinant_proteins" title="Category:Recombinant proteins">Recombinant proteins</a></li></ul></div><div class="mw-hidden-catlinks mw-hidden-cats-hidden" id="mw-hidden-catlinks">Hidden categories: <ul><li><a href="/wiki/Category:CS1_errors:_external_links" title="Category:CS1 errors: external links">CS1 errors: external links</a></li><li><a href="/wiki/Category:CS1_errors:_dates" title="Category:CS1 errors: dates">CS1 errors: dates</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_May_2014" title="Category:Articles lacking reliable references from May 2014">Articles lacking reliable references from May 2014</a></li><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:Wikipedia_articles_that_are_too_technical_from_May_2014" title="Category:Wikipedia articles that are too technical from May 2014">Wikipedia articles that are too technical from May 2014</a></li><li><a href="/wiki/Category:All_articles_that_are_too_technical" title="Category:All articles that are too technical">All articles that are too technical</a></li><li><a href="/wiki/Category:Articles_with_multiple_maintenance_issues" title="Category:Articles with multiple maintenance issues">Articles with multiple maintenance issues</a></li><li><a href="/wiki/Category:Official_website_not_in_Wikidata" title="Category:Official website not in Wikidata">Official website not in Wikidata</a></li></ul></div></div>
</div>
</div>
<div id="mw-data-after-content">
<div class="read-more-container"></div>
</div>
<div id="mw-navigation">
<h2>Navigation menu</h2>
<div id="mw-head">
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-personal-label" class="vector-menu" id="p-personal" role="navigation">
<h3 id="p-personal-label">
<span>Personal tools</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a accesskey="n" href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]">Talk</a></li><li id="pt-anoncontribs"><a accesskey="y" href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=NGR-hTNF+%28antitumor+recombinant+protein%29" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a accesskey="o" href="/w/index.php?title=Special:UserLogin&amp;returnto=NGR-hTNF+%28antitumor+recombinant+protein%29" title="You're encouraged to log in; however, it's not mandatory. [o]">Log in</a></li></ul>
</div>
</nav>
<div id="left-navigation">
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-namespaces-label" class="vector-menu vector-menu-tabs vectorTabs" id="p-namespaces" role="navigation">
<h3 id="p-namespaces-label">
<span>Namespaces</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li class="selected" id="ca-nstab-main"><a accesskey="c" href="/wiki/NGR-hTNF_(antitumor_recombinant_protein)" title="View the content page [c]">Article</a></li><li id="ca-talk"><a accesskey="t" href="/wiki/Talk:NGR-hTNF_(antitumor_recombinant_protein)" rel="discussion" title="Discuss improvements to the content page [t]">Talk</a></li></ul>
</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-variants-label" class="vector-menu-empty emptyPortlet vector-menu vector-menu-dropdown vectorMenu" id="p-variants" role="navigation">
<input aria-labelledby="p-variants-label" class="vector-menu-checkbox vectorMenuCheckbox" type="checkbox"/>
<h3 id="p-variants-label">
<span>Variants</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="menu vector-menu-content-list"></ul>
</div>
</nav>
</div>
<div id="right-navigation">
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-views-label" class="vector-menu vector-menu-tabs vectorTabs" id="p-views" role="navigation">
<h3 id="p-views-label">
<span>Views</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li class="selected" id="ca-view"><a href="/wiki/NGR-hTNF_(antitumor_recombinant_protein)">Read</a></li><li id="ca-edit"><a accesskey="e" href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=edit" title="Edit this page [e]">Edit</a></li><li id="ca-history"><a accesskey="h" href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=history" title="Past revisions of this page [h]">View history</a></li></ul>
</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-cactions-label" class="vector-menu-empty emptyPortlet vector-menu vector-menu-dropdown vectorMenu" id="p-cactions" role="navigation">
<input aria-labelledby="p-cactions-label" class="vector-menu-checkbox vectorMenuCheckbox" type="checkbox"/>
<h3 id="p-cactions-label">
<span>More</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="menu vector-menu-content-list"></ul>
</div>
</nav>
<div id="p-search" role="search">
<h3>
<label for="searchInput">Search</label>
</h3>
<form action="/w/index.php" id="searchform">
<div data-search-loc="header-moved" id="simpleSearch">
<input accesskey="f" id="searchInput" name="search" placeholder="Search Wikipedia" title="Search Wikipedia [f]" type="search"/>
<input name="title" type="hidden" value="Special:Search"/>
<input class="searchButton mw-fallbackSearchButton" id="mw-searchButton" name="fulltext" title="Search Wikipedia for this text" type="submit" value="Search"/>
<input class="searchButton" id="searchButton" name="go" title="Go to a page with this exact name if it exists" type="submit" value="Go"/>
</div>
</form>
</div>
</div>
</div>
<div id="mw-panel">
<div id="p-logo" role="banner">
<a class="mw-wiki-logo" href="/wiki/Main_Page" title="Visit the main page"></a>
</div>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-navigation-label" class="vector-menu vector-menu-portal portal portal-first" id="p-navigation" role="navigation">
<h3 id="p-navigation-label">
<span>Navigation</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li id="n-mainpage-description"><a accesskey="z" href="/wiki/Main_Page" title="Visit the main page [z]">Main page</a></li><li id="n-contents"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Articles related to current events">Current events</a></li><li id="n-randompage"><a accesskey="x" href="/wiki/Special:Random" title="Visit a randomly selected article [x]">Random article</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works">About Wikipedia</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact us</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation">Donate</a></li></ul>
</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-interaction-label" class="vector-menu vector-menu-portal portal" id="p-interaction" role="navigation">
<h3 id="p-interaction-label">
<span>Contribute</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-introduction"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia">Learn to edit</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors">Community portal</a></li><li id="n-recentchanges"><a accesskey="r" href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]">Recent changes</a></li><li id="n-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Add images or other media for use on Wikipedia">Upload file</a></li></ul>
</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-tb-label" class="vector-menu vector-menu-portal portal" id="p-tb" role="navigation">
<h3 id="p-tb-label">
<span>Tools</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li id="t-whatlinkshere"><a accesskey="j" href="/wiki/Special:WhatLinksHere/NGR-hTNF_(antitumor_recombinant_protein)" title="List of all English Wikipedia pages containing links to this page [j]">What links here</a></li><li id="t-recentchangeslinked"><a accesskey="k" href="/wiki/Special:RecentChangesLinked/NGR-hTNF_(antitumor_recombinant_protein)" rel="nofollow" title="Recent changes in pages linked from this page [k]">Related changes</a></li><li id="t-upload"><a accesskey="u" href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]">Upload file</a></li><li id="t-specialpages"><a accesskey="q" href="/wiki/Special:SpecialPages" title="A list of all special pages [q]">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;oldid=951192383" title="Permanent link to this revision of this page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;action=info" title="More information about this page">Page information</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=NGR-hTNF_%28antitumor_recombinant_protein%29&amp;id=951192383&amp;wpFormIdentifier=titleform" title="Information on how to cite this page">Cite this page</a></li><li id="t-wikibase"><a accesskey="g" href="https://www.wikidata.org/wiki/Special:EntityPage/Q17637123" title="Structured data on this page hosted by Wikidata [g]">Wikidata item</a></li></ul>
</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-coll-print_export-label" class="vector-menu vector-menu-portal portal" id="p-coll-print_export" role="navigation">
<h3 id="p-coll-print_export-label">
<span>Print/export</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li id="coll-download-as-rl"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=NGR-hTNF_%28antitumor_recombinant_protein%29&amp;action=show-download-screen" title="Download this page as a PDF file">Download as PDF</a></li><li id="t-print"><a accesskey="p" href="/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;printable=yes" title="Printable version of this page [p]">Printable version</a></li></ul>
</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav aria-labelledby="p-lang-label" class="vector-menu vector-menu-portal portal" id="p-lang" role="navigation">
<h3 id="p-lang-label">
<span>Languages</span>
</h3>
<!-- Please do not use the .body class, it is deprecated. -->
<div class="body vector-menu-content">
<!-- Please do not use the .menu class, it is deprecated. -->
<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-it"><a class="interlanguage-link-target" href="https://it.wikipedia.org/wiki/NGR-hTNF_proteina_ricombinante_antitumorale" hreflang="it" lang="it" title="NGR-hTNF proteina ricombinante antitumorale – Italian">Italiano</a></li></ul>
<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a class="wbc-editpage" href="https://www.wikidata.org/wiki/Special:EntityPage/Q17637123#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></span></div>
</div>
</nav>
</div>
</div>
<footer class="mw-footer" id="footer" role="contentinfo">
<ul id="footer-info">
<li id="footer-info-lastmod"> This page was last edited on 15 April 2020, at 23:28<span class="anonymous-show"> (UTC)</span>.</li>
<li id="footer-info-copyright">Text is available under the <a href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License" rel="license">Creative Commons Attribution-ShareAlike License</a><a href="//creativecommons.org/licenses/by-sa/3.0/" rel="license" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>
<ul id="footer-places">
<li id="footer-places-privacy"><a class="extiw" href="https://foundation.wikimedia.org/wiki/Privacy_policy" title="wmf:Privacy policy">Privacy policy</a></li>
<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
<li id="footer-places-mobileview"><a class="noprint stopMobileRedirectToggle" href="//en.m.wikipedia.org/w/index.php?title=NGR-hTNF_(antitumor_recombinant_protein)&amp;mobileaction=toggle_view_mobile">Mobile view</a></li>
<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Cookie_statement">Cookie statement</a></li>
</ul>
<ul class="noprint" id="footer-icons">
<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img alt="Wikimedia Foundation" height="31" loading="lazy" src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88"/></a></li>
<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img alt="Powered by MediaWiki" height="31" loading="lazy" src="/static/images/footer/poweredby_mediawiki_88x31.png" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88"/></a></li>
</ul>
<div style="clear: both;"></div>
</footer>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.316","walltime":"0.405","ppvisitednodes":{"value":1079,"limit":1000000},"postexpandincludesize":{"value":72626,"limit":2097152},"templateargumentsize":{"value":7200,"limit":2097152},"expansiondepth":{"value":19,"limit":40},"expensivefunctioncount":{"value":2,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":86949,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00%  372.357      1 -total"," 54.86%  204.287      1 Template:Reflist"," 30.69%  114.283      1 Template:Multiple_issues"," 28.23%  105.111     10 Template:Cite_web"," 28.09%  104.602      3 Template:Ambox"," 11.03%   41.073      6 Template:Citation"," 10.03%   37.329      1 Template:Official_website","  7.71%   28.713      1 Template:Technical","  7.64%   28.445      4 Template:Cite_journal","  6.00%   22.353      1 Template:Third-party"]},"scribunto":{"limitreport-timeusage":{"value":"0.188","limit":"10.000"},"limitreport-memusage":{"value":5122096,"limit":52428800}},"cachereport":{"origin":"mw2333","timestamp":"20201005081409","ttl":2592000,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"NGR-hTNF (antitumor recombinant protein)","url":"https:\/\/en.wikipedia.org\/wiki\/NGR-hTNF_(antitumor_recombinant_protein)","sameAs":"http:\/\/www.wikidata.org\/entity\/Q17637123","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q17637123","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2014-05-15T13:42:11Z","dateModified":"2020-04-15T23:28:19Z"}</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":122,"wgHostname":"mw2225"});});</script>
</body></html>